Author Question: A patient tells the clinic nurse that he or she has been taking over-the-counter (OTC) Pepcid to ... (Read 40 times)

Haya94 · **on:** Jul 23, 2018

A patient tells the clinic nurse that he or she has been taking over-the-counter (OTC) Pepcid to relieve acid indigestion for several years. This is the first time the patient has ever reported this issue to a health care provider.

As part of the teaching plan for this patient, the nurse explains what risk associated with not sharing OTC drug use with the provider? A) The OTC drug could be more expensive than seeking health care advice.
B) The drug could mask symptoms of a serious problem that is undiagnosed.
C) Use of the drug could cause a rebound effect of Pepcid.
D) The drug could interact with several cold medicines.

Question 2

What drug would the nurse expect to administer to the patient experiencing malignant hyperthermia?

A) Orphenadrine
B) Metaxalone
C) Chlorzoxazone
D) Dantrolene

macagn · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

D
Feedback:
OTC drugs allow patients to self-diagnose and treat routine signs and symptoms without seeing a health care provider. This self-prescribed treatment, however, could mask a more serious underlying medical problem and result in a poor outcome for the patient. The issues of drug rebound and drug interaction need to be considered, but the safety issue related to self-diagnosis and self-prescription presents the greatest risk to the patient. Patients should always be encouraged to discuss the use of OTC products with their health care provider.

Answer to Question 2

D
Feedback:
Indications for dantrolene include control of clinical spasticity resulting from upper motor neuron disorders; preoperatively to prevent or attenuate the development of malignant hyperthermia in susceptible patients; IV for management of fulminant malignant hyperthermia. The other drugs are not indicated for treatment of malignant hyperthermia.